Could a national database of scientific misconduct rulings stop repeat offenders?

Mark Barnes (courtesy of Ropes and Gray LLC)

In an editorial published today in Science, Michael Lauer and Mark Barnes call for greater transparency in investigations of scientific misconduct with an aim toward making sure prospective academic employers know of applicants’ past misdeeds. As we’ve reported, in the absence of transparency around findings of misconduct, some universities have discovered too late they hired someone who has turned out to be a serial offender.

Lauer, who served as Deputy Director for Extramural Research at the National Institutes of Health from 2015-2025, and Barnes, a partner at Ropes and Gray LLC in Boston who has served as acting research integrity officer at several U.S. institutions, propose a tracking system similar to the National Practitioner Data Bank (NPDB). That database logs adverse actions and malpractice payments as a way to inform decisions about individual physicians by hospitals. As Lauer and Barnes note, federal law “requires a hospital to query the NPDB whenever it is considering a new applicant for medical privileges, as well as to conduct repeat queries every 2 years to make sure information on staff is up to date.” We asked Barnes to elaborate on the ideas presented in the op-ed. (He notes he is speaking only for himself here.)

Retraction Watch: You write in your op-ed universities may avoid sharing personal information — presumably including results of misconduct investigations — for fear of legal claims of defamation or violations of privacy. Are those fears valid? 

Continue reading Could a national database of scientific misconduct rulings stop repeat offenders?

A journal named a sleuth in a correction. The sleuth says that was ‘ethical editorial malpractice’

As the publishing community debates the merits of naming sleuths in retraction or correction notices, one journal did so without the sleuth’s permission — by publishing an email from the authors naming her as the correction notice. 

The sleuth calls it “ethical editorial malpractice.” The publisher says it was an “administrative error.” After Retraction Watch reached out for comment, the journal removed the text of the email from the correction notice. 

The paper, on trends in chronic kidney disease in people with lupus, appeared in BMC Nephrology in August.

Continue reading A journal named a sleuth in a correction. The sleuth says that was ‘ethical editorial malpractice’

Publisher changes citation, registration policies following Retraction Watch investigation

Wolters Kluwer global headquarters in the Netherlands

The Dutch publisher Wolters Kluwer has scrapped some of its citation and study-registration requirements at a top-ranked surgery journal founded by the U.K. plastic surgeon Riaz Agha, Retraction Watch has learned.

The move follows our investigation last month that found mandatory citation of reporting guidelines developed by Agha and published in the International Journal of Surgery (IJS) had inflated the impact factor of the open-access title, making it more attractive to authors and readers.

A blanket requirement to register all human studies before manuscript submission, contrary to recommendations from the International Committee of Medical Journal Editors, appeared to serve another of Agha’s business interests: a paid research registry he founded in 2015.

Continue reading Publisher changes citation, registration policies following Retraction Watch investigation

Bloodhound code sniffs out copied-and-pasted numerical data

Pexels

Markus Englund, a software developer and sleuth based in the Netherlands, first hit paydirt with invasive plant species in China. After having scanned 12 other published scientific datasets with his novel detection software with no results, he came across one showing something suspicious: rows and rows of measurements of plant roots repeated across entirely different species. 

“I was really excited,” he said in a recent call with Retraction Watch. “I couldn’t think of any innocent explanation for why that would be the case.” 

Englund had built a tool dedicated to “purging” fabricated data by identifying “impossible” data in spreadsheets available on open repositories, according to Science Detective, his site about the initiative. From his initial review, he has found 18 datasets containing duplicated values that are possibly serious enough to need correcting — including one from an influential paper on Parkinson’s disease, as The Transmitter recently reported. (Retraction Watch’s cofounder Ivan Oransky is that publication’s editor-in-chief.)

Continue reading Bloodhound code sniffs out copied-and-pasted numerical data

Weekend reads: Half of social science ‘doesn’t replicate’; ‘Scientific ghosts: Life after retraction’; multisensory learning paper retracted

If your week flew by — we know ours did — catch up here with what you might have missed.

The week at Retraction Watch featured:

In case you missed the news, the Hijacked Journal Checker now has more than 400 entries. The Retraction Watch Database has over 64,000 retractions. Our list of COVID-19 retractions is up to 650, and our mass resignations list has more than 50 entries. We keep tabs on all this and more. If you value this work, please consider showing your support with a tax-deductible donation. Every dollar counts.

I Support Retraction Watch

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Continue reading Weekend reads: Half of social science ‘doesn’t replicate’; ‘Scientific ghosts: Life after retraction’; multisensory learning paper retracted

Guest post: Should universities investigate questionable papers students and faculty wrote elsewhere?

Be-Art/iStock

I am a research ethicist and often get asked by my university to investigate when potential concerns are raised about our staff or students. One example involved the recent case of the alleged paper mill and self-citation activities by Hitler Louis and Innocent Benjamin. The matter raised significant questions about who within the research community has the responsibility to act when concerns like this are raised.

Regular readers of Retraction Watch know that detecting alleged research misconduct is a haphazard affair. Frequently a university will find out about concerns after being notified by research integrity sleuths writing under pseudonyms. In this case, “Cisticola Tinniens” informed us that one of our current MSc students (Benjamin) had an unusually high number of publications for his early career stage, with some highlighted on the PubPeer website as potentially problematic.

The first thing we did was to check to see whether our university was named in any of these papers, as clearly institutions do have a responsibility for research attributed to our researchers or students. We found only one of the suspect papers named us directly, and since the work definitely had not occurred at our institution, it was relatively easy to get this affiliation corrected almost immediately.

Continue reading Guest post: Should universities investigate questionable papers students and faculty wrote elsewhere?

Judge tosses lawsuit over controversial Paxil ‘Study 329’

A judge has dismissed a legal challenge aimed at forcing Elsevier to retract a long-criticized study that concluded the antidepressant Paxil was safe and effective for teens.

The 2001 paper, published in the Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP), has faced scrutiny for more than 20 years by critics who say the study has led to unwarranted and potentially harmful prescribing of the drug to youth. As we reported last October, the journal placed an expression of concern on the paper shortly after a lawsuit was filed by attorney George W. Murgatroyd III against the journal’s owner, the American Academy of Child and Adolescent Psychiatry (AACAP), and Elsevier, which publishes the title.

In his complaint, filed in the Superior Court of the District of Columbia, Murgatroyd claimed the journal is violating the D.C. Consumer Protection Procedures Act (CPPA) by continuing to “publish, distribute, and sell a fraudulent scientific article that contains material facts” that mislead the public and endanger adolescent mental health and safety. AACAP and Elsevier are profiting from the article by charging readers to buy access to the paper, according to the complaint. 

Continue reading Judge tosses lawsuit over controversial Paxil ‘Study 329’

Biology journal ghosts researcher after holding paper hostage 

In a story readers might find familiar, a researcher was asked to pay when he demanded a journal retract an article he had never seen but supposedly wrote — and the journal ghosted him when he refused. 

In February, Evgenios Agathokleous, an environmental resources researcher at Nanjing University of Information Science & Technology in China, asked Prime Scholars’ European Journal of Experimental Biology to retract a 2023 article that listed him as the sole author. In his email to the journal, he said he had never seen the paper and asked the journal to remove it and publish a formal retraction notice. 

Two days later, a Prime Scholars representative named Nina responded, telling Agathokleous “your article has already been successfully published in our journal in accordance with the company’s publication norms and policies.” Nina then asked Agathokleous to pay 519 euros, the equivalent of roughly $600, which they said “covers the costs associated with publication handling, indexing preparation, and database maintenance.”

Continue reading Biology journal ghosts researcher after holding paper hostage 

BMJ retracts cardiac stem cell paper, removes authors months after sleuths flag data ‘mismatch’

The BMJ has retracted a paper on stem cell therapy for heart failure after sleuths flagged the work for “serious” inconsistencies in data.

Published in October, the paper reported the results of a phase III clinical trial of more than 400 patients in Shiraz, Iran, looking at whether stem cell therapy lowers the risk of heart failure after a heart attack. The journal announced the results in a press release, and news of the findings appeared in several outlets. New Scientist called the study the “strongest evidence yet that stem cells can help the heart repair itself.”

A week after the study was published, sleuths took to PubPeer to point out inconsistencies between the data reported in the article and the dataset uploaded with it. The concerns included a “curious repeating pattern” of records in the dataset and a high number of integers for the height and weight of patients. 

Continue reading BMJ retracts cardiac stem cell paper, removes authors months after sleuths flag data ‘mismatch’

Jury to decide whether Duke retaliated against researcher who reported sexual harassment

Duke University School of Medicine

A jury will soon decide whether leaders at Duke University accused a researcher of misconduct in retaliation for her reporting sexual harassment at the institution. 

U.S. Magistrate Judge Patrick Auld ruled Brahmajothi Mulugu provided enough evidence to show the timing of Duke’s misconduct investigation against her may have been retaliatory, allowing Mulugu’s legal challenge to proceed. In his Jan. 16 decision, Auld denied a motion by Duke to end the lawsuit, concluding a jury should weigh whether Mulugu’s sexual harassment report fueled the university’s misconduct actions against the scientist. 

Mulugu, an immunologist in Duke’s Department of Pharmacology and Cancer Biology, sued the university in 2023, alleging leaders conducted an “unjustified” research misconduct investigation after she reported sexual harassment by then-professor Mohamed Bahie Abou-Donia. The university’s Office of Institutional Equity (OIE) substantiated Mulugu’s harassment report in November 2020, and Abou-Donia resigned, according to a case summary in Auld’s decision. 

Continue reading Jury to decide whether Duke retaliated against researcher who reported sexual harassment